Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2025-12-24 @ 9:49 PM
NCT ID:
NCT01567332
Eligibility Criteria:
Inclusion Criteria:
* Age 18-80 years of two sexes
* Cerebral infarction older than 12 months
* NIH score \> 4
* Patient able to walk with or without technical assistance, Rankin score greater than or equal to 3
* No changes can interfere with treatment of spasticity in the 3 months preceding the study (benzodiazepines, baclofen, dantrolene, botulinum toxin ...)
* No history of generalized epilepsy unbalanced
* Free and informed consent signed by the patient
* MRI with ancient anatomical sequence confirming the accident sylvian
Exclusion Criteria:
* Stroke with motor sequelae of cerebral infarction prior to qualifying
* Alteration of the course prior to stroke
* Generalized epilepsy unbalanced
* Arrhythmias untreated
* Injection of botulinum toxin in the previous 4 months of randomization and 2 months after randomization
* Severe aphasia or cognitive impairment that interferes with the understanding of the tasks
* Presence of ferromagnetic material intracranial
* Pacemaker
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01567332
Study Brief:
Protocol Section:
NCT01567332